SAN DIEGO, July 19, 2018 /PRNewswire/ -- Evofem
Biosciences, Inc., (NASDAQ: EVFM) ("Evofem"), a clinical-stage
biopharmaceutical company committed to developing and
commercializing innovative products to address unmet needs in
women's sexual and reproductive health, will hold a conference call
to discuss financial results and business highlights for the
quarter ended June 30, 2018, as follows:
Date
|
Thursday August 2,
2018
|
Time
|
11:00 a.m.
EDT
|
Dial-in
numbers
|
(866) 503-5561
(U.S. toll-free) or (253) 336-2965
|
Passcode
|
2086111
|
Webcast (live and
archived)
|
www.evofem.com under
"Investors" or click here
|
The teleconference replay will be available approximately two
hours after completion through Tuesday, August 7, 2018,
at (855) 859-2056 (U.S.) or (404) 537-3406
(International). The replay access code is 2086111. The
archived webcast will be available via the aforementioned
URLs.
About Evofem Biosciences
Evofem Biosciences, Inc.,
(NASDAQ: EVFM) is a clinical-stage biopharmaceutical company
committed to developing and commercializing innovative products to
address unmet needs in women's sexual and reproductive health.
Evofem is leveraging its proprietary Multi-purpose Prevention
Technology vaginal gel to develop product candidates for multiple
indications, including contraception, the prevention of urogenital
transmission of chlamydia and gonorrhea in women, and recurrent
bacterial vaginosis. For more information regarding Evofem, please
visit www.evofem.com.
Evofem Biosciences' Contact
Amy Raskopf
Investor Relations
araskopf@evofem.com
858-550-1900 x167
View original content with
multimedia:http://www.prnewswire.com/news-releases/evofem-biosciences-to-report-second-quarter-2018-results-and-provide-corporate-update-on-august-2-2018-300682789.html
SOURCE Evofem Biosciences, Inc.